We have collected information about A Non-Covalent Peptide-Based Strategy For Sirna Delivery for you. Follow the links to find out details on A Non-Covalent Peptide-Based Strategy For Sirna Delivery.
https://www.ncbi.nlm.nih.gov/pubmed/17233597
A non-covalent peptide-based strategy for siRNA delivery. Crombez L(1), Charnet A, Morris MC, Aldrian-Herrada G, Heitz F, Divita G. Author information: (1)Centre de Recherches de Biochimie Macromoléculaire, CRBM-CNRS, Department of Molecular Biophysics and Therapeutics, 1919 Route de Mende, 34293 Montpellier, France.Author: L. Crombez, A. Charnet, M.C. Morris, G. Aldrian-Herrada, F. Heitz, G. Divita
https://www.researchgate.net/publication/47680675_A_Non-Covalent_Peptide-Based_Strategy_for_siRNA_Delivery
A Non-Covalent Peptide-Based Strategy for siRNA Delivery Article in Methods in molecular biology (Clifton, N.J.) 683:349-60 · January 2011 with 30 Reads How we measure 'reads'
https://portlandpress.com/biochemsoctrans/article/35/1/44/63970/A-non-covalent-peptide-based-strategy-for-siRNA
Conjugation strategy with either Transportan or Penetratin has been successfully applied to improve the delivery of siRNA into cultured cells. We have developed a non-covalent peptide-based strategy for the delivery of molecules into mammalian cells, using short amphipathic peptides that form stable complexes with cargoes [8,9].Author: L. Crombez, A. Charnet, M.C. Morris, G. Aldrian-Herrada, F. Heitz, G. Divita
https://link.springer.com/protocol/10.1007%2F978-1-60761-919-2_25
Oct 12, 2010 · Cell-penetrating peptide Peptide-based non-covalent strategy Amphiphatic peptide Non-endosomal pathway siRNA delivery This is a preview of subscription content, log in to check access. Springer Nature is developing a new tool to find and evaluate Protocols.Author: L. Crombez, A. Charnet, M.C. Morris, G. Aldrian-Herrada, F. Heitz, G. Divita
https://www.researchgate.net/profile/Laurence_Crombez_Campion/publication/6568383_A_non-covalent_peptide-based_strategy_for_siRNA_delivery_Figure_1/links/0c96051e85a22908cd000000.pdf?inViewer=true&pdfJsDownload=true&disableCoverPage=true&origin=publication_detail
44 Biochemical Society Transactions (2007) Volume 35, part 1 A non-covalent peptide-based strategy for siRNA delivery L. Crombez, A. Charnet, M.C. Morris, G. Aldrian-Herrada, F. Heitz and G ...
https://www.sciencedirect.com/science/article/pii/S0169409X07002888
1. Introduction. Protein and nucleic-acid-based therapeutic molecules such as peptide nucleic acids (PNAs) and their derivatives or siRNA have provided new perspectives for pharmaceutical research , , , , , , .However, their development is limited by their low stability in vivo, their poor cellular uptake and inefficient cellular trafficking.To circumvent these problems, efforts have been ...Author: Sébastien Deshayes, May Morris, Frédéric Heitz, Gilles Divita
https://www.ncbi.nlm.nih.gov/pubmed/21748633
Cell-penetrating peptides constitute very promising tools for non-invasive cellular import of oligonucleotides and analogs. We recently described a non-covalent strategy based on short amphiphatic peptides (MPG8/PEP3) that have been successfully applied ex vivo and in vivo for the delivery of therapeutic siRNA and PNA molecules.Author: Laurence Crombez, May C. Morris, Frederic Heitz, Gilles Divita
Searching for A Non-Covalent Peptide-Based Strategy For Sirna Delivery?
You can just click the links above. The data is collected for you.
